24 December 2015 in Frontiers in Microbiology
Antifungal drugs belong to few chemical groups and such low diversity limits the therapeutic choices. The urgent need of innovative options has pushed researchers to search new bioactive molecules. Literature regarding the last 15 years reveals that different research groups have used different approaches to achieve such goal. However, the discovery of molecules with different mechanisms of action still demands considerable time and efforts. This review was conceived to present how Pharmaceutical Biotechnology might contribute to the discovery of molecules with antifungal properties by microbial biotransformation procedures. Authors present some aspects of (1) microbial biotransformation of herbal medicines and food; (2) possibility of major and minor molecular amendments in existing molecules by biocatalysis; (3) methodological improvements in processes involving whole cells and immobilized enzymes; (4) potential of endophytic fungi to produce antimicrobials by bioconversions; and (5) in silico research driving to the improvement of molecules. All these issues belong to a new conception of transformation procedures, so-called “green chemistry”, which aims the highest possible efficiency with reduced production of waste and the smallest environmental impact.
1 July 2008 in Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology
PAPatrícia Del Vigna de Almeida
Patrícia Del Vigna de Almeida
SISérgio Aparecido Ignácio
+1
1 September 2009 in Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology
IBIvana Maria Saes Busato
SISérgio Aparecido Ignácio
1 June 2008 in Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology
IWIverson Ernani Cogo Woyceichoski
Iverson Ernani Cogo Woyceichoski
LRLuciane Grochocki Resende
Luciane Grochocki Resende
ALAntonio Adilson Soares de Lima
Antonio Adilson Soares de Lima
+1
1 March 2010 in Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology
IBIvana Maria Saes Busato
MBMônica Sommer Bittencourt
Mônica Sommer Bittencourt
22 October 2019 in Scientific Reports
Drug addiction remains a prevalent and fatal disease worldwide that carries significant social and economic impacts. Recent reports suggest illicit pregabalin (Lyrica) use may be increasing among youth, however the addictive potential of pregabalin has not been well established. Drug seeking behavior and chronic drug use are associated with deficits in glutamate clearance and activation of postsynaptic glutamatergic receptors. In the current study, we investigated the abuse potential of pregabalin using conditioned place preference (CPP) paradigm. Different doses of pregabalin (30, 60, 90, and 120 mg/kg) were used to assess the seeking behavior in mice. Glutamate homeostasis is maintained by glutamate transporter type-1 (GLT-1), which plays a vital role in clearing the released glutamate from synapses and drug seeking behavior. Therefore, we investigated the role of glutamate in pregabalin-seeking behavior with ceftriaxone (CEF), a potent GLT-1 upregulator. Mice treated with pregabalin 60 and 90 mg/kg doses demonstrated drug seeking-like behavior, which was significantly blocked by CEF pretreatment. These results suggest that pregabalin-induced CPP was successfully modulated by CEF which could serve as a lead compound for developing treatment for pregabalin abuse.